Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours. Maekawa N, Konnai S, Hosoya K, Kim S, et al. PLoS One 2023;18:e0291727.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maekawa N, Konnai S, Hosoya K, Kim S, et al. Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours. PLoS One 2023;18:e0291727.
PMID: 37792729